Skip to main content
SpringerLink
Log in

5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effects of a range of 5-HT receptor antagonists were examined in an animal model of anxiety — the social interaction test. Six antagonists with high affinity for 5-HT1C receptors; mianserin, (+) mianserin, 1-naphthyl piperazine, ICI 169 369, pizotifen and LY 53857 all increased the time spent in active social interaction by pairs of weight-matched rats under high light unfamiliar conditions. As locomotion was only increased by 1-NP and then only at high doses, the effect of the drugs is consistent with anxiolysis. These properties were shared by the benzodiazepine anxiolytic chlordiazepoxide but not by the specific 5-HT2 antagonists ketanserin and altanserin, nor by the 5-HT1A and 5-HT1B antagonists cyanopindolol and pindolol. Similarly, neither the adrenergic α2 antagonist idazoxan, the α2 antagonist and putative 5-HT1D partial agonist yohimbine nor the H1 antagonist mepyramine had any significant effect. Since (+)mianserin, LY 53857 and ICI 169 369 at least have low affinity for 5-HT3 receptors these receptors are also unlikely to be involved. The results therefore imply that the observed anxiolytic effects of the drugs are likely to be mediated by 5-HT1C receptor blockade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alexander BS, Wood MD (1987) Stereoselective blockade of central (3-H) 5-Hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B and 5-HT1C) by mianserin and propranolol. J Pharm Pharmacol 39:664–666

    PubMed  Google Scholar 

  • Becker HC (1986) Comparison of the effects of the benzodiazepine midazolam and three serotonin antagonists on a consummatory conflict paradigm. Pharmacol Biochem Behav 24:1057–1064

    Google Scholar 

  • Blackburn TP, Thornber CW, Pearce RJ, Cox B (1988) In vitro studies with ICI 169 369, a chemically novel 5-HT antagonist. Eur J Pharmacol 150:247–256

    Article  PubMed  Google Scholar 

  • Caccia S, Ballabio M, Samanin R (1981) m-Chlorophenylpiperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 34:477–478

    Google Scholar 

  • Ceulemans DLS, Hoppenbrouwers MLJA, Gelders YG, Reyntjens AJM (1985) The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303–305

    PubMed  Google Scholar 

  • Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist mCPP in panic disorder patients and healthy patients. Psychopharmacology 92:14–21

    Article  PubMed  Google Scholar 

  • Clineschmidt BV, Flataker LM, Faison E, Holmes R (1979) An in vivo model for investigating α1 and α2-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn 242:59–76

    PubMed  Google Scholar 

  • Cohen ML, Fuller RW, Kurz KD (1983) LY 53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneous hypertensive rat. J Pharmacol Exp Ther 227:327–332

    PubMed  Google Scholar 

  • Colpaert FC, Meert TF, Niemegeers CJE, Janssen PAJ (1985) Behavioural and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in the rat. Psychopharmacology 86:45–54

    Article  PubMed  Google Scholar 

  • Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors. J Pharmacol Exp Ther 242:552–557

    PubMed  Google Scholar 

  • Conti L, Pinder RM (1979) A controlled comparative trial of mian-serin and diazepam in the treatment of anxiety states in psychiatric outpatients. J Int Med Res 7:285–289

    PubMed  Google Scholar 

  • Cook L, Sepinwall J (1975) Behavioural analysis of the effects and mechanisms of action of benzodiazepines. In: Costa E, Greengard P (eds) Mechanisms of action of benzodiazepines. Raven Press, New York, pp 1–28

    Google Scholar 

  • Costall B, Domeney AM, Gerrard PA, Kelly ME, Naylor RJ (1988) Zacopride: anxiolytic profile in rodent and primate models of anxiety. J Pharm Pharmacol 40:302–305

    PubMed  Google Scholar 

  • Deacon R, Gardner CF (1986) Benzodiazepine and 5-HT ligands in a rat conflict test. Br J Pharmacol 88:330P

    Google Scholar 

  • File SE (1981) Behavioural effects of serotonin depletion. In: Clifford Rose E (ed) Metabolic disorders of the nervous system. Pitmans, London, pp 429–445

    Google Scholar 

  • File SE (1985) Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour. Neuropsychobiology 13:55–62

    PubMed  Google Scholar 

  • Gadie B, Lane AC, McCarthy PS, Tulloch IF, Walter DS (1983) 2-Alkyl analogues of RX 781094: potent selctive antagonists at central α2-adrenoceptors. Br J Pharmacol 78:312P

    Google Scholar 

  • Gardner CR (1986) Recent developments in 5-HT-related pharmacology of of animal models of anxiety. Pharmacol Biochem Behav 24:1479–1485

    Article  PubMed  Google Scholar 

  • Gleeson S, Ahlers ST, Mansbach RS, Foust JM, Barrett JE (1989) Behavioural studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809–817

    PubMed  Google Scholar 

  • Glennon RA, El-Kader A, Ismaiel M, McCarthy BG, Peroutka SJ (1989) Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study. Eur J Pharmacol 168:387–392

    Article  PubMed  Google Scholar 

  • Graeff FG (1974) Tryptamine antagonists and punished behaviour. J Pharmacol Exp Ther 189:344–350

    PubMed  Google Scholar 

  • Graeff FG, Zuarde AW, Giglio JS, Lima Filho EC, Karniol IG (1985) Effect of metergoline on human anxiety. Psychopharmacology 86:334–338

    Google Scholar 

  • Guy AP, Gardner CR (1985) Pharmacological characterization of a modified social interaction model of anxiety in the rat. Neuropsychobiology 13:194–201

    PubMed  Google Scholar 

  • Hoyer D (1989) 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Fozard J (ed) Peripheral actions of 5-HT. Oxford University Press, Oxford, pp 72–99

    Google Scholar 

  • Hoyer D (1990) Competitive antagonism by recognised 5-HT2 receptor antagonists at 5-HT1C receptors. Naunyn Schmiedeberg's Arch Pharmacol 341:Suppl R88

  • Hoyer D, Pazos A, Probst A, Palacios JM (1986) Serotonin receptors in the human brain. 1. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96

    Article  PubMed  Google Scholar 

  • Jones BJ, Costall B, Domeney AM, Kelly ME, Naylor RJ, Oakley NR, Tyers MB (1988) The potential anxiolytic activity of GR 38032F, a 5-HT3-receptor antagonist. Br J Pharmacol 93:985–993

    PubMed  Google Scholar 

  • Kahn RS, Van Praag HM, Wetzler S, Asnis GM, Barr G (1988) Serotonin and anxiety revisited. Biol Psychiatry 23:189–208

    Article  PubMed  Google Scholar 

  • Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, Van Praag HM (1990) Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology 100:339–344

    Google Scholar 

  • Kennett GA, Curzon G (1988a) Evidence that mCPP may have behavioural effects mediated by 5-HT1C receptors. Br J Pharmacol 94:137–147

    PubMed  Google Scholar 

  • Kennett GA, Curzon G (1988b) Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia by RU 24969 only requires 5-HT1B receptors. Psychopharmacology 96:93–100

    Google Scholar 

  • Kennett GA, Blackburn TP (1990) Anxiolytic-like actions of BRL 46470A — a novel 5-HT3 receptor antagonist. J Psychopharmacology 4:4

    Google Scholar 

  • Kennett GA, Curzon (1991) Potencies of antagonists indicate that 5-HT1C receptors mediate 1–3(chlorophenyl) piperazine-induced hypophagia. Br J Pharmacol 103:2016–2020

    PubMed  Google Scholar 

  • Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 141:137–147

    Article  Google Scholar 

  • Kennett GA, Whitton P, Shah K, Curzon G (1989) Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol 164:445–454

    Article  PubMed  Google Scholar 

  • Kennett GA, Whitton P, Curzon G (1990) ID50 values of antagonists vs mCPP-induced hypophagia and 5-HT2-mediated headshakes indicate that 5-HT1C sites mediate the hypophagia. Br J Pharmacol 99:241P

  • Khan MC, Bennie EH, Stulemeijer SM, Ravens MA (1983) Mianserin and doxepin in the treatment of outpatient depression with anxiety. Br J Clin Pharmacol 15:213S-218S

    PubMed  Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB (1988) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–749

    Article  Google Scholar 

  • Leone CML, De Aguir JC, Graeff FG (1983) Role of 5-hydroxytryptamine in amphetamine effects on punished and unpunished behaviour. Psychopharmacology 80:78–82

    Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R41 468, a novel antagonist of 5-HT2 receptors. Life Sci 28:1015–1022

    Article  PubMed  Google Scholar 

  • Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch Pharmacol 321:165–170

    Article  Google Scholar 

  • Mason P, Skinner J, Luttinger D (1987) Two tests in rats for antianxiety effect of clinically anxiety attenuating antidepressants. Psychopharmacology 92:30–33

    Google Scholar 

  • Mueller EA, Murphy DL, Sunderland T (1985) Neuroendocrine effects of m-chlorophenylpiperazine, a serotonin agonist in humans. J Clin Endocrinol Metab 61:1179–1184

    PubMed  Google Scholar 

  • Murphy JE (1978) Mianserin in the treatment of depressive illness and anxiety states in general practice. Br J Clin Pharmacol 5:81S-85S

    PubMed  Google Scholar 

  • Nelson DR, Thomas DR (1989) (3-H)-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes. Biochem Pharmacol 10:1693–1695

    Article  Google Scholar 

  • Nicholson VS, Wieringa JH, Van Delft AML (1982) Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin. Naunyn-Schmiedeberg's Arch Pharmacol 319:48–55

    Article  Google Scholar 

  • Niesink RJM, Van Ree JM (1982) Antidepressant drugs normalise the increased social behaviour of pairs of male rats induced by short term isolation. Neuropharmacology 21:1343–1348

    Article  PubMed  Google Scholar 

  • Pigott TA, Zohar J, Hill JL, Bernstein SE, Grover GN, Zohar-Kadouch RC, Murphy DL (1990) Metergoline blocks the behavioural and neuroendocrine effects of orally administered mCPP in obsessive-compulsive disorder. Biol Psychiatry 29:418–426

    Article  Google Scholar 

  • Piper D, Upton N, Thomas DL, Nicholass J (1988) The effects of 5-HT3 receptor antagonists BRL 43694 and GR 38032F in animal models of anxiety. Br J Pharmacol 94:314P

  • Russell GFM, Niaz U, Wakeling A, Slade PD (1978) Comparative double-blind trial of mianserin hydrochloride (Organon GB94) and diazepam in patients with depressive illness. Br J Clin Pharmacol 5:57S-65S

    PubMed  Google Scholar 

  • Schoeffter P, Hoyer D (1989a) Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Naunyn-Schmiedeberg's Arch Pharmacol 339:675–682

    Article  Google Scholar 

  • Schoeffter P, Hoyer D (1989b) 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some β-adrenoceptor antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 340:285–292

    Google Scholar 

  • Seibyl JP, Krystal JH, Price LH, Woods SW, Heninger GR, Charney DS (1989) 5-HT function in the biochemical and behavioural responses to mCPP in healthy subjects and schizophrenics. Am Soc Neurosci Abstr 15:485.21

    Google Scholar 

  • Sepinwall J, Cook L (1980) Mechanism of action of the benzodiazepines: Behavioral aspect. Fed Proc 39:3024–3031

    PubMed  Google Scholar 

  • Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487

    PubMed  Google Scholar 

  • Stein L, Wise CD, Belluzzi JD (1975) Effects of benzodiazepines on central serotonergic mechanisms. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines. Raven Press, New York, pp 29–44

    Google Scholar 

  • Tricklebank MD, Forler C, Fozard J (1984) The involvement of subtypes of the 5-HT1A receptor and of catecholaminergic systems in the behavioural response to 8-Hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271–277

    Article  PubMed  Google Scholar 

  • Whitton P, Curzon G (1990) Anxiogenic-like effect of infusing 1-(3-chlorophenyl)piperazine (mCPP) into the hippocampus. Psychopharmacology 100:138–140

    Google Scholar 

  • Winter JD (1972) Comparison of chlordiazepoxide, methysergide and cinanserin as modifiers of punished behaviour and as antagonists of N,N-dimethyltryptamine. Arch Int Pharmacodyn Ther 197:147–159

    PubMed  Google Scholar 

  • Zohar J, Insel TR (1987) Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 22:667–687

    Article  PubMed  Google Scholar 

  • Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 45:167–172

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SmithKline Beecham Pharmaceuticals, Coldharbour Road, The Pinnacles, CM19 5AD, Harlow, Essex, UK

    G. A. Kennett

Authors
  1. G. A. Kennett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kennett, G.A. 5-HT1C receptor antagonists have anxiolytic-like actions in the rat social interaction model. Psychopharmacology 107, 379–384 (1992). https://doi.org/10.1007/BF02245165

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245165

Key words

Search

Navigation